MDXG
MiMedx Group, Inc.NASDAQHealthcare$3.92-0.76%ClosedMarket Cap: $582.4M
As of 2026-04-06
Valuation
P/E (TTM)
11.99
PEG
0.83
P/B
2.24
P/S
1.38
EV/EBITDA
5.32
DCF Value
$3.62
FCF Yield
12.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
82.6%
Operating Margin
15.3%
Net Margin
11.6%
ROE
21.2%
ROA
14.2%
ROIC
16.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $118.1M | 83.9% | $21.1M | $15.2M | $0.10 | — |
| FY 2025 | $418.6M | 82.6% | $63.9M | $48.6M | $0.32 | — |
| Q3 2025 | $113.7M | 83.5% | $22.2M | $16.7M | $0.11 | — |
| Q2 2025 | $98.6M | 81.1% | $12.4M | $9.6M | $0.06 | — |
| Q1 2025 | $88.2M | 81.2% | $8.3M | $7.0M | $0.05 | — |
| Q4 2024 | $92.9M | 81.8% | $11.1M | $7.4M | $0.05 | — |
| FY 2024 | $348.9M | 82.8% | $58.9M | $42.4M | $0.28 | — |
| Q3 2024 | $84.1M | 81.8% | $11.2M | $8.1M | $0.05 | — |
| Q2 2024 | $87.2M | 82.7% | $23.4M | $17.6M | $0.12 | — |
| Q1 2024 | $84.7M | 84.4% | $13.2M | $9.3M | $0.06 | — |
| Q4 2023 | $86.8M | 84.1% | $15.5M | $53.5M | $0.35 | — |
| FY 2023 | $321.5M | 83.0% | $37.1M | $67.4M | $0.38 | — |